Jbm (Healthcare) Ltd
HKEX:2161

Watchlist Manager
Jbm (Healthcare) Ltd Logo
Jbm (Healthcare) Ltd
HKEX:2161
Watchlist
Price: 2.67 HKD -0.37% Market Closed
Market Cap: 2.2B HKD

Net Margin
Jbm (Healthcare) Ltd

25.2%
Current
15%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
25.2%
=
Net Income
197.3m
/
Revenue
782.3m

Net Margin Across Competitors

No Stocks Found

Jbm (Healthcare) Ltd
Glance View

Market Cap
2.2B HKD
Industry
Pharmaceuticals

JBM (Healthcare) Ltd. functions as an investment holding company. The company employs 274 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The firm operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.

Intrinsic Value
4.35 HKD
Undervaluation 39%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
25.2%
=
Net Income
197.3m
/
Revenue
782.3m
What is the Net Margin of Jbm (Healthcare) Ltd?

Based on Jbm (Healthcare) Ltd's most recent financial statements, the company has Net Margin of 25.2%.

Back to Top